Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. The study starting Wednesday will be one of the world's largest coronavirus vaccine studies so far, testing the shot in 60,000 volunteers in the U.S., South Africa,...
J&J to Stop Selling Talc-Based Baby Powder in US, Canada
FAIRLESS HILLS, Pa. — Johnson & Johnson is ending sales of its iconic talc-based Johnson’s Baby Powder in the U.S. and Canada, where demand has dwindled amid thousands of lawsuits claiming it has caused cancer. The world’s biggest maker of health care products said Tuesday the talc-based powder will still...
After Bankruptcy Filing, Purdue Pharma May Not Be off Hook
Purdue Pharma filed for bankruptcy in the first step in a complex, multibillion-dollar plan by the maker of OxyContin to settle thousands of lawsuits brought against it by state and local governments over the nation's deadly opioid disaster. The company and members of the Sackler family, which owns it, expressed...
Judge Orders Drugmaker to Pay $572 Million in Opioid Lawsuit
NORMAN, Okla. — An Oklahoma judge on Monday found Johnson & Johnson and its subsidiaries helped fuel the state's opioid crisis and ordered the consumer products giant to pay $572 million, more than twice the amount another drug manufacturer agreed to pay in a settlement. Cleveland County District Judge Thad...
Jury Delivers $26M Verdict in Baby Powder Cancer Case
LOS ANGELES — A California jury delivered a $25.7 million verdict against Johnson & Johnson in a lawsuit brought by a woman who claimed she developed cancer by using the company's talc-based baby powder. Jurors in Los Angeles recommended $4 million in punitive damages Thursday after finding the company acted...